The Trump administration relies almost entirely on user fees for the FDA’s funding boost in FY 2021 to more than $6.2bn, up $265.3m from the FY 2020 enacted level, according to t. However, 90.4% of the increase would come from proposed and existing user fee revenue.

The White House included a $25.4m increase in budget authority for the agency and nearly $240m in additional user fee dollars. But the $160.8m user fee increase includes around 67% in OTC monograph and other proposed programs.

The user fee increase also includes an expansion of the FDA’s tobacco product fee, but those fees would leave the agency center if Congress agrees with the administration’s proposal to make its Center for Tobacco Products a separate agency within the Department of Health and Human Services.

FDA Budget Request Includes $5M For CBD Regulation With Pathway Unclear

More from Regulation

More from Policy & Regulation